Small Molecule Inhibitor for Treatment of Obesity and Type 2 Diabetes
The use of small molecular inhibitor is a new and developing area of pharmaceutical interest for identifying and evluating mechanisms assciated with complex drug discovery pathways to treat obesity and type 2 diabetes.
This technology is available for exclusive licensing.
